In a research report released Wednesday, Maxim analyst Jason Kolbert reiterated a Buy rating on shares of Pluristem Therapeutics Inc. (NASDAQ:PSTI) with an $8 price …
In a research report released Monday, Maxim Group analyst Jason Kolbert maintained a Buy rating on shares of Pluristem Therapeutics Inc. (NASDAQ:PSTI) with an …
In a research report released today, MLV’s healthcare analyst Vernon Bernardino reiterated a Buy rating on shares of Pluristem Therapeutics Inc (NASDAQ:PSTI), with a $6 …
Youku Tudou Inc (ADR) (NYSE:YOKU) shares slipped more than -6% in pre-market trading down to $18.77 after Chinese shares fell more than 8%.
Quick commercialization of drugs in clinical trials has long been held as a fantasy for makers of pharmaceuticals and biologics. With recent news, …
Maxim Group’s healthcare analyst Jason Kolbert weighed in today with research reports on the Canadian urology company Sophiris Bio Inc (NASDAQ:SPHS), Israeli stem cell company Pluristem Therapeutics Inc. (NASDAQ:PSTI), …
Pluristem Therapeutics Inc. (NASDAQ:PSTI) shares rose 8.
In a research report published Tuesday, MLV analyst Vernon Bernardino maintained a Buy rating on Pluristem Therapeutics Inc. (NASDAQ:PSTI) with a price target …
In a research report sent to investors today, MLV analyst George Zavoico maintained a Buy rating on Pluristem Therapeutics (NASDAQ:PSTI) with a $6.00 …
In a research report issued this morning, H.C.
